Neonatology Questions and Controversies: Infectious Disease, Immunology, and Pharmacology
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Other Volumes in the Neonatology Questions and Controversies Series - p. iii 5. Copyright - p. iv 6. Contributors - p. v 7. Series Foreword - p. ix 8. Preface - p. xi 9. List of Illustrations - p. xii 10. List of Tables - p. xiii 11. SECTION 1. Infectious Disease - p. 1 12. 1. Management of the asymptomatic newborn at risk for sepsis - p. 2 13. 2. Empiric therapy for neonatal sepsis - p. 15 14. 3. When and how to treat neonatal CMV infection - p. 25 15. 4. Neonatal herpes simplex virus infection - p. 35 16. 5. Antibiotic stewardship - p. 43 17. 6. Neonatal fungal infections - p. 56 18. 7. When to perform lumbar puncture in infants at risk for meningitis in the neonatal intensive care unit - p. 73 19. 8. Perinatal and neonatal considerations in COVID-19 - p. 90 20. 9. Congenital syphilis - p. 99 21. 10. Gonococcal eye prophylaxis—are mandates still justified? - p. 116 22. 11. Organ dysfunction in sepsis and necrotizing enterocolitis - p. 125 23. SECTION 2. Pharmacology - p. 139 24. 12. Antibiotic considerations for necrotizing enterocolitis - p. 140 25. 13. Antiseizure medications and treatments in neonates - p. 146 26. 14. Neuroprotective therapies in newborns - p. 165 27. 15. Pharmacological therapy of neonatal abstinence syndrome - p. 180 28. 16. Vasodilator drugs for pulmonary hypertension in bronchopulmonary dysplasia - p. 198 29. 17. Drug-associated acute kidney injury in neonates - p. 212 30. SECTION 3. Immunology - p. 223 31. 18. Recent advances and controversies in inborn errors of immunity presenting in the newborn period - p. 224 32. 19. Clinical and molecular markers to assist decision-making in neonatal sepsis - p. 243 33. Index - p. 258
Neonatology Questions and Controversies: Infectious Disease, Immunology, and Pharmacology
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Other Volumes in the Neonatology Questions and Controversies Series - p. iii 5. Copyright - p. iv 6. Contributors - p. v 7. Series Foreword - p. ix 8. Preface - p. xi 9. List of Illustrations - p. xii 10. List of Tables - p. xiii 11. SECTION 1. Infectious Disease - p. 1 12. 1. Management of the asymptomatic newborn at risk for sepsis - p. 2 13. 2. Empiric therapy for neonatal sepsis - p. 15 14. 3. When and how to treat neonatal CMV infection - p. 25 15. 4. Neonatal herpes simplex virus infection - p. 35 16. 5. Antibiotic stewardship - p. 43 17. 6. Neonatal fungal infections - p. 56 18. 7. When to perform lumbar puncture in infants at risk for meningitis in the neonatal intensive care unit - p. 73 19. 8. Perinatal and neonatal considerations in COVID-19 - p. 90 20. 9. Congenital syphilis - p. 99 21. 10. Gonococcal eye prophylaxis—are mandates still justified? - p. 116 22. 11. Organ dysfunction in sepsis and necrotizing enterocolitis - p. 125 23. SECTION 2. Pharmacology - p. 139 24. 12. Antibiotic considerations for necrotizing enterocolitis - p. 140 25. 13. Antiseizure medications and treatments in neonates - p. 146 26. 14. Neuroprotective therapies in newborns - p. 165 27. 15. Pharmacological therapy of neonatal abstinence syndrome - p. 180 28. 16. Vasodilator drugs for pulmonary hypertension in bronchopulmonary dysplasia - p. 198 29. 17. Drug-associated acute kidney injury in neonates - p. 212 30. SECTION 3. Immunology - p. 223 31. 18. Recent advances and controversies in inborn errors of immunity presenting in the newborn period - p. 224 32. 19. Clinical and molecular markers to assist decision-making in neonatal sepsis - p. 243 33. Index - p. 258
